Rheumatoid arthritis by Melchiorre, Daniela et al.
Hindawi Publishing Corporation
Autoimmune Diseases
Volume 2013, Article ID 958437, 2 pages
http://dx.doi.org/10.1155/2013/958437
Editorial
Rheumatoid Arthritis
Daniela Melchiorre,1 Anna Maria Iagnocco,2 Suchitra Acharya,3
Guglielmina Pepe,4 and Marco Borderi5
1 Department of Experimental and Clinical Medicine, Rheumatology, University of Florence, Florence, Italy
2 Department of Rheumatology, The Sapienza University of Rome, Rome, Italy
3 Bleeding Disorders and Thrombosis Program, Cohen Children’s Medical Center of New York, NY, USA
4Department of Experimental and Clinical Medicine, Critical Medical Care, University of Florence,
Florence, Italy
5 Infectious Diseases Unit, University of Bologna, Bologna, Italy
Correspondence should be addressed to Daniela Melchiorre; daniela.melchiorre@unifi.it
Received 17 November 2013; Accepted 17 November 2013
Copyright © 2013 Daniela Melchiorre et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Our team have worked together to ensure the best con-
tribution and the greater impact of each accepted paper.
Independent peer review remains a central part of the quality-
control process applied to the publication of the scientific
literature. All papers published are scrutinized by the editors,
and those considered suitable are sent to two or three expert
referees. In addition, each paper is allocated to a member
of the editorial board specifically responsible for ensuring
the adequacy of the peer-review process and providing an
additional perspective regarding the quality of the paper.
Papers are only accepted for publication after authors have
satisfactorily addressed the issues raised by referees and
the editors. Thus, in addition to peer review, key quality-
control roles are exercised at multiple steps in the publication
process by the editors to ensure the effectiveness, impartiality,
and integrity of the peer-review and editorial processes.
Furthermore, the six accepted papers, reported at the end,
have tackled the topics of the special issue, for each of its
arguments: (1) from molecular pathways to clinical trials;
(2) predisease—what happens before diagnosis; (3) pain in
rheumatic diseases and other arthropathies; (4) sonographic
exam and clinical aspects in RA; (5) anti-TNF blockers and
comorbidities in RA; (6) comorbidities in rheumatic diseases;
rehabilitation and quality of life in RA; (7) muscle growth
and atrophy in acute and chronic inflammation; (8) genetics
and regulation of immune response; (9) bone and cartilage-
regeneration—imaging. Some of them have opened up new
areas for research in rheumatology. Others have developed
a new point of view in regard to the etiopathogenesis, as the
role of the hormones in the females orDNAdamages, and the
therapy in rheumatoid arthritis. Others have contributed to
a better understanding of comorbidities that sometimes may
be unsuccessful effective therapies if not properly considered.
Everyone shall expand with their publication a more fruitful
discussion on this rheumatic disease that is still disabling
and seriously compromises the quality of life of patients
who suffer. We have worked with great pleasure and being
satisfied we conclude this special issue, hoping to repeat this
challenging experience. Finally, we hope to have broadened,
at least in part, together with the authors the knowledge and
research in rheumatology.
The accepted papers are as follows.
(1) “Total knee arthroplasty considerations in rheumatoid
arthritis,” by J. R. Danoff et al.
(2) “Laryngeal manifestations of rheumatoid arthritis,” by
A. L. Hamdan and D. Sarieddine.
(3) “Restless legs syndrome as a comorbidity in rheumatoid
arthritis,” by J. A. Gjevre and R. M. Taylor Gjevre.
(4) “The role of simvastatin in the therapeutic approach of
rheumatoid arthritis,” by L. Cojocaru et al.
(5) “Lower serum androstenedione levels in pre-rheuma-
toid arthritis versus normal control women: correla-
tions with lower serum cortisol levels,” by A. T. Masi
et al.
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(6) “DNA damage in rheumatoid arthritis: an age-de-
pendent increase in the lipid peroxidation-derived
DNA adduct, heptanone-etheno-2󸀠-deoxycytidine,” by
T. Hamasaki et al.
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